The Stallion India IPO will open on January 16, 2025, and close on January 20, 2025. This is a Book Built Issue aiming to raise ₹199.45 crores, comprising a fresh issue of ₹160.73 crores and an offer for sale of up to 43,02,656 equity shares with a face value of ₹10 each. The price band for the IPO is set at ₹85 to ₹90 per share, with a retail investor quota of 35%, QIB at 50%, and HNI at 15%. The IPO is scheduled to list on the BSE and NSE on January 23, 2025, with allotment finalized on January 21, 2025. Financially, the company reported revenue of ₹236.23 crores in 2024, up from ₹226.06 crores in 2023, and profits of ₹14.79 crores in 2024 compared to ₹9.75 crores in 2023, reflecting consistent growth. With proceeds allocated for expansion and operational strengthening, the IPO is considered a promising long-term investment opportunity.
Founded in 2002, Stallion India Fluorochemicals Limited is a rapidly growing company specializing in the supply and production of refrigerants and a wide variety of gases. With nearly two decades of expertise in debulking, bottling, and distributing fluorochemicals, the company has established itself as a significant player in the industry.
Stallion India is also renowned for developing custom gas formulations by combining two or more gases to create innovative products. The company’s portfolio primarily includes two main types of gases: HFC (hydrofluorocarbon) and HFO (hydrofluoroolefin), which serve a broad spectrum of industries.
Stallion India operates four state-of-the-art facilities located in:
Their gases find applications in diverse sectors, including:
Stallion India aims to expand its offerings across a broader range of gases and solidify its position as a trusted leader in the industry.
In the first half of FY 2023 (April to September), the company achieved operational revenue of ₹9,274.39 crores.